• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MR 引导下微波消融治疗肝细胞癌(HCC):全身麻醉是否比局部麻醉更有效?

MR-guided microwave ablation of hepatocellular carcinoma (HCC): is general anesthesia more effective than local anesthesia?

机构信息

Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, No. 1 Jianshe East Road, Zhengzhou City, 450000, Henan Province, China.

出版信息

BMC Cancer. 2021 May 17;21(1):562. doi: 10.1186/s12885-021-08298-2.

DOI:10.1186/s12885-021-08298-2
PMID:34001036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8130145/
Abstract

BACKGROUND

Percutaneous magnetic resonance-guided (MR-guided) MWA procedures have traditionally been performed under local anesthesia (LA) and sedation. However, pain control is often difficult to manage, especially in some cases when the tumor is large or in a specific location, such as near the abdominal wall or close to the hepatic dome. This study retrospectively compared the results of general anesthesia (GA) and local anesthesia (LA) for MR-guided microwave ablation (MWA) in patients with hepatocellular carcinoma (HCC ≤ 5.0 cm) to investigate whether different anesthesia methods lead to different clinical outcomes.

METHODS

The results of the analysis include procedure-related complications, imaging response, and the time to complete two sets of procedures. According to the type of anesthesia, the Kaplan-Meier method was used to compare the local tumor progression (LTP) of the two groups who underwent MR-guided MWA.

RESULTS

All patients achieved technical success. The mean ablation duration of each patient in the GA group and LA group was remarkably different (P = 0.012). Both groups had no difference in complications or LTP (both P > 0.05). Notably, the tumor location (challenging locations) and the number of lesions (2-3 lesions) could be the main factors affecting LTP (p = 0.000, p = 0.015). Univariate Cox proportional hazard regression indicated that using different anesthesia methods (GA and LA) was not associated with longer LTP (P = 0.237), while tumor location (challenging locations) and the number of lesions (2-3 lesions) were both related to shorter LTP (P = 0.000, P = 0.020, respectively). Additionally, multivariate Cox regression further revealed that the tumor location (regular locations) and the number of lesions (single) could independently predict better LTP (P = 0.000, P = 0.005, respectively).

CONCLUSIONS

No correlation was observed between GA and LA for LTP after MR-guided MWA. However, tumors in challenging locations and the number of lesions (2-3 lesions) appear to be the main factors affecting LTP.

摘要

背景

经皮磁共振引导(MR 引导)微波消融(MWA)程序传统上是在局部麻醉(LA)和镇静下进行的。然而,疼痛控制往往难以管理,特别是在某些情况下,如肿瘤较大或位于特定位置,如靠近腹壁或靠近肝顶。本研究回顾性比较了全身麻醉(GA)和局部麻醉(LA)在 MR 引导微波消融(MWA)治疗肝细胞癌(HCC≤5.0cm)患者中的结果,以探讨不同麻醉方法是否会导致不同的临床结果。

方法

分析结果包括与程序相关的并发症、影像学反应以及完成两组程序的时间。根据麻醉类型,采用 Kaplan-Meier 法比较两组接受 MR 引导 MWA 的患者的局部肿瘤进展(LTP)。

结果

所有患者均获得技术成功。GA 组和 LA 组每位患者的平均消融时间差异显著(P=0.012)。两组并发症或 LTP 无差异(均 P>0.05)。值得注意的是,肿瘤位置(挑战性位置)和病灶数量(2-3 个病灶)可能是影响 LTP 的主要因素(p=0.000,p=0.015)。单因素 Cox 比例风险回归表明,使用不同麻醉方法(GA 和 LA)与较长的 LTP 无关(P=0.237),而肿瘤位置(挑战性位置)和病灶数量(2-3 个病灶)均与较短的 LTP 相关(P=0.000,P=0.020)。此外,多因素 Cox 回归进一步表明,肿瘤位置(规则位置)和病灶数量(单发)可独立预测更好的 LTP(P=0.000,P=0.005)。

结论

MR 引导 MWA 后 GA 和 LA 与 LTP 之间无相关性。然而,位于挑战性位置的肿瘤和病灶数量(2-3 个病灶)似乎是影响 LTP 的主要因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfad/8130145/cb5c700ceca4/12885_2021_8298_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfad/8130145/e5a9a2857e27/12885_2021_8298_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfad/8130145/605c97913e4b/12885_2021_8298_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfad/8130145/edcd3c32a2c5/12885_2021_8298_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfad/8130145/cb5c700ceca4/12885_2021_8298_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfad/8130145/e5a9a2857e27/12885_2021_8298_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfad/8130145/605c97913e4b/12885_2021_8298_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfad/8130145/edcd3c32a2c5/12885_2021_8298_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cfad/8130145/cb5c700ceca4/12885_2021_8298_Fig4_HTML.jpg

相似文献

1
MR-guided microwave ablation of hepatocellular carcinoma (HCC): is general anesthesia more effective than local anesthesia?MR 引导下微波消融治疗肝细胞癌(HCC):全身麻醉是否比局部麻醉更有效?
BMC Cancer. 2021 May 17;21(1):562. doi: 10.1186/s12885-021-08298-2.
2
Image-guided microwave ablation of hepatocellular carcinoma (≤5.0 cm): is MR guidance more effective than CT guidance?图像引导微波消融治疗肝细胞癌(≤5.0cm):MR 引导是否比 CT 引导更有效?
BMC Cancer. 2021 Apr 7;21(1):366. doi: 10.1186/s12885-021-08099-7.
3
General versus local anesthesia for percutaneous radiofrequency ablation of hepatocellular carcinoma at unusual regions.全身麻醉与局部麻醉在经皮射频消融治疗非常规部位肝细胞癌中的应用比较。
J Cancer Res Ther. 2020;16(7):1686-1690. doi: 10.4103/jcrt.JCRT_1187_20.
4
Multiparametric magnetic resonance-guided and monitored microwave ablation in liver cancer.多参数磁共振引导及监测下的肝癌微波消融术
J Cancer Res Ther. 2020;16(7):1625-1633. doi: 10.4103/jcrt.JCRT_1024_20.
5
Clinical outcome of medium-sized hepatocellular carcinoma treated with microwave ablation.微波消融治疗中大型肝细胞癌的临床疗效
World J Gastroenterol. 2015 Mar 14;21(10):2997-3004. doi: 10.3748/wjg.v21.i10.2997.
6
Microwave ablation compared with radiofrequency ablation for the treatment of liver cancer: a systematic review and meta-analysis.微波消融与射频消融治疗肝癌的疗效比较:系统评价和荟萃分析。
Radiol Oncol. 2021 Jun 25;55(3):247-258. doi: 10.2478/raon-2021-0030.
7
Propofol Compared to Midazolam Sedation and to General Anesthesia for Percutaneous Microwave Ablation in Patients with Hepatic Malignancies: A Single-Center Comparative Analysis of Three Historical Cohorts.丙泊酚与咪达唑仑镇静及全身麻醉用于肝恶性肿瘤经皮微波消融术的比较:三个历史队列的单中心比较分析。
Cardiovasc Intervent Radiol. 2019 Nov;42(11):1597-1608. doi: 10.1007/s00270-019-02273-y. Epub 2019 Jun 26.
8
Comparison of Microwave and Radiofrequency Ablation for the Treatment of Small- and Medium-Sized Hepatocellular Carcinomas in a Prospective Randomized Trial.前瞻性随机试验比较微波与射频消融治疗小肝癌及中肝癌的疗效。
Rofo. 2024 May;196(5):482-490. doi: 10.1055/a-2203-2733. Epub 2023 Dec 8.
9
Efficacy and safety of percutaneous microwave ablation for hepatocellular carcinomas <4 cm in difficult location.经皮微波消融治疗困难部位直径<4 cm肝细胞癌的疗效与安全性
Br J Radiol. 2020 Dec 1;93(1116):20191025. doi: 10.1259/bjr.20191025. Epub 2020 Oct 6.
10
Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis.小的单发性血管周围肝细胞癌:应用倾向评分分析比较射频消融和微波消融
Eur Radiol. 2021 Jul;31(7):4764-4773. doi: 10.1007/s00330-020-07571-5. Epub 2021 Jan 5.

引用本文的文献

1
Threatment Strategies for Recurrent Hepatocellular Carcinoma Patients: Ablation and its Combination Patterns.复发性肝细胞癌患者的治疗策略:消融及其联合模式。
J Cancer. 2024 Feb 25;15(8):2193-2205. doi: 10.7150/jca.93885. eCollection 2024.
2
Local anaesthesia vs. general anaesthesia for percutaneous microwave ablation in hepatocellular carcinoma: efficacy, safety, and cost analysis.局部麻醉与全身麻醉用于肝细胞癌经皮微波消融的疗效、安全性及成本分析
Front Oncol. 2023 Sep 12;13:1186133. doi: 10.3389/fonc.2023.1186133. eCollection 2023.
3
Personalized nursing improves physical condition and life quality of patients undergoing interventional therapy for liver cancer.

本文引用的文献

1
Image-guided microwave ablation of hepatocellular carcinoma (≤5.0 cm): is MR guidance more effective than CT guidance?图像引导微波消融治疗肝细胞癌(≤5.0cm):MR 引导是否比 CT 引导更有效?
BMC Cancer. 2021 Apr 7;21(1):366. doi: 10.1186/s12885-021-08099-7.
2
Making timely remedial measures after TACE based on the results of cone-beam CT liver perfusion.基于锥形束 CT 肝脏灌注结果,在 TACE 后及时采取补救措施。
Int J Hyperthermia. 2021;38(1):428-436. doi: 10.1080/02656736.2021.1895331.
3
Transcatheter Arterial Chemoembolization Combined with Simultaneous Cone-beam Computed Tomography-guided Microwave Ablation in the Treatment of Small Hepatocellular Carcinoma: Clinical Experiences From 50 Procedures.
个性化护理可改善肝癌介入治疗患者的身体状况和生活质量。
Am J Transl Res. 2021 Dec 15;13(12):14220-14228. eCollection 2021.
经导管动脉化疗栓塞联合锥形束计算机断层扫描引导下微波消融治疗小肝细胞癌 50 例临床经验
Acad Radiol. 2021 Nov;28 Suppl 1:S64-S70. doi: 10.1016/j.acra.2020.08.036. Epub 2020 Oct 13.
4
The effect of tumor location on long-term results of microwave ablation for early-stage hepatocellular carcinoma.肿瘤位置对早期肝细胞癌微波消融长期疗效的影响。
Abdom Radiol (NY). 2020 Nov;45(11):3923-3933. doi: 10.1007/s00261-020-02472-z.
5
Effects of general anesthesia versus local anesthesia in primary hepatocellular carcinoma patients presenting for thermal ablation surgery: a multiple center retrospective cohort study with propensity score matching.全身麻醉与局部麻醉对接受热消融手术的原发性肝细胞癌患者的影响:一项采用倾向评分匹配的多中心回顾性队列研究
Ann Transl Med. 2020 Mar;8(6):277. doi: 10.21037/atm.2020.03.88.
6
Epidemiology of Hepatocellular Carcinoma.肝细胞癌的流行病学
Hepatology. 2021 Jan;73 Suppl 1(Suppl 1):4-13. doi: 10.1002/hep.31288. Epub 2020 Nov 24.
7
Beneficial body mass index to enhance survival outcomes in patients with early-stage hepatocellular carcinoma following microwave ablation treatment.体重指数有益,可提高经微波消融治疗的早期肝细胞癌患者的生存结局。
Int J Hyperthermia. 2020;37(1):110-118. doi: 10.1080/02656736.2020.1712482.
8
mRECIST for HCC: Performance and novel refinements.肝癌的改良RECIST标准:性能与新改进
J Hepatol. 2020 Feb;72(2):288-306. doi: 10.1016/j.jhep.2019.09.026.
9
[Percutaneous MR-guided prostate cancer cryoablation: Predictive factors and oncologic outcomes].[经皮磁共振引导下前列腺癌冷冻消融:预测因素与肿瘤学结局]
Prog Urol. 2020 Jan;30(1):12-18. doi: 10.1016/j.purol.2019.10.006. Epub 2019 Dec 11.
10
Transcatheter arterial chemoembolization combined with radiofrequency or microwave ablation for hepatocellular carcinoma: a review.经动脉化疗栓塞联合射频或微波消融治疗肝细胞癌:综述
Hepat Oncol. 2018 Sep 28;5(2):HEP07. doi: 10.2217/hep-2018-0001. eCollection 2018 Apr.